Publication Date
1-1-2024
Journal
Hormone Research in Paediatrics
DOI
10.1159/000543034
PMID
39657603
PMCID
PMC11854989
PubMedCentral® Posted Date
12-10-2024
PubMedCentral® Full Text Version
Post-print
Published Open-Access
yes
Keywords
Humans, Adolescent, Child, Insulin, Insulin Infusion Systems, Diabetes Mellitus, Type 1, Hypoglycemic Agents, Societies, Medical, Male, Female, Consensus, Young Adult, Pump, Automated insulin delivery, Children, Diabetes
Abstract
The International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines represent a rich repository that serves as the only comprehensive set of clinical recommendations for children, adolescents, and young adults living with diabetes worldwide. This chapter builds on the 2022 ISPAD guidelines, and summarizes recent advances in the technology behind insulin administration, with special emphasis on insulin pump therapy, especially on glucose-responsive integrated technology that is feasible with the use of automated insulin delivery (AID) systems in children and adolescents. The International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines represent a rich repository that serves as the only comprehensive set of clinical recommendations for children, adolescents, and young adults living with diabetes worldwide. This chapter builds on the 2022 ISPAD guidelines, and summarizes recent advances in the technology behind insulin administration, with special emphasis on insulin pump therapy, especially on glucose-responsive integrated technology that is feasible with the use of automated insulin delivery (AID) systems in children and adolescents.
Included in
Endocrine System Diseases Commons, Endocrinology, Diabetes, and Metabolism Commons, Mental and Social Health Commons, Neurosciences Commons, Pediatrics Commons, Psychiatry and Psychology Commons
